Sun Pharmaceutical Industries Limited Share Price and Company Fundamentals
Last traded: Yesterday at 9:45 AM
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.
Key Metrics
PE ratio
37.32
PB ratio
5.38
Dividend yield
0.85%
Beta
0.12
Market cap
₹4498.99B
Enterprise value
₹4213.20B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 47000 |
| Website | https://sunpharma.com |
| Mailing address | Sun House CTS No. 201 B/1 Western Express Highway Goregaon (East) Mumbai 400063 India |
| Phone / Fax | 91 22 4324 4324 / 91 22 4324 4343 |
Dividends
Dividend yield
0.85%
Dividend amount
₹16.00
Payout ratio
31.75%
5Y Avg. yield
-%
Sun Pharmaceutical Industries Limited paid ₹16.00 dividend and the ex-dividend date was 07 Jul 2026.The dividend payout ratio is 31.75%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SUNPHARMA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Aug 2026, following are the company executives and directors listed on Sun Pharmaceutical Industries Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Dilip Shantilal Shanghvi | Executive Chairman of the Board | 70 | |
| Mr. Kirti Wardhaman Ganorkar | Managing Director | 58 | |
| Mr. Aalok Dilip Shanghvi | COO, Head of Global Generics R&D, Business Devp., and Whole Time Director | 41 | |
| Ms. Vidhi Dilip Shanghvi | Whole-time Director | 38 | |
| Ms. Jayashree Satagopan | Executive VP & CFO | 57 | |
| Mr. Dheeraj Prasad Sinha BE | EVP & Chief Information Officer | 54 | |
| Dr. Abhishek Sharma | VP, Head of Investor Relations & Strategic Projects | ||
| Mr. Anoop Deshpande | Company Secretary & Compliance Officer | ||
| Mr. Kalyanasundaram Subramanian | Director of Corporate Development | 71 | |
| Ms. Sana Shaikh | Head of Marketing |
Profitability and management effectiveness
Profit margin
20.19%
Operating margin
23.25%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Sun Pharmaceutical Industries Limited is 4498.99B and its enterprise value is 4213.20B. The enterprise value to revenue ratio of SUNPHARMA is 7.03. The enterprise value to EBITDA ratio of SUNPHARMA is 25.41.
The SUNPHARMA's stocks Beta value is 0.12 making it 88% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Frequently Asked Questions
1. What is Sun Pharmaceutical Industries Limited's Stock Symbol?
Sun Pharmaceutical Industries Limited trades on NSE under the ticker symbol "SUNPHARMA".
2. What is Sun Pharmaceutical Industries Limited's stock price today?
One share of SUNPHARMA stock can currently be purchased for approximately ₹1875.1.
3. How can I contact Sun Pharmaceutical Industries Limited?
Sun Pharmaceutical Industries Limited's mailing address is Sun House CTS No. 201 B/1 Western Express Highway Goregaon (East) Mumbai 400063 India. The company can be reached via phone at 91 22 4324 4324.
4. What is Sun Pharmaceutical Industries Limited's official website?
The official website of Sun Pharmaceutical Industries Limited is https://sunpharma.com.